FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2115813710> ?p ?o ?g. }

• W2115813710 endingPage "2704" @default.
• W2115813710 startingPage "2695" @default.
• W2115813710 abstract "To provide recommendations on the appropriate use of breast tumor biomarker assay results to guide decisions on systemic therapy for metastatic breast cancer.A literature search and prospectively defined study selection identified systematic reviews, meta-analyses, randomized controlled trials (RCTs), prospective-retrospective studies, and prospective comparative observational studies published from 2006 through September 2014.The literature search revealed 17 articles that met criteria for further review: 11 studies reporting discordances between primary tumors and metastases in expression of hormone receptors or human epidermal growth factor receptor 2 (HER2), one RCT that addressed the use of a biomarker to decide whether to change or continue a treatment regimen, and five prospective-retrospective studies that evaluated the clinical utility of biomarkers.In patients with accessible metastases, biopsy for confirmation of disease process and retesting of estrogen receptor, progesterone receptor, and HER2 status should be offered, but evidence is lacking to determine whether changing anticancer treatment on the basis of change in receptor status affects clinical outcomes. With discordance of results between primary and metastatic tissues, the Panel consensus is to use preferentially the estrogen receptor, progesterone receptor, and HER2 status of the metastasis to direct therapy if supported by the clinical scenario and patient's goals for care. Carcinoembryonic antigen, cancer antigen 15-3, and cancer antigen 27-29 may be used as adjunctive assessments, but not alone, to contribute to decisions regarding therapy. Recommendations for tumor rebiopsy and use of circulating tumor markers are based on clinical experience and Panel informal consensus in the absence of studies designed to evaluate the clinical utility of the markers. As such, it is also reasonable for clinicians to not use these markers as adjunctive assessments." @default.
• W2115813710 created "2016-06-24" @default.
• W2115813710 creator A5001315712 @default.
• W2115813710 creator A5002951950 @default.
• W2115813710 creator A5005611441 @default.
• W2115813710 creator A5008665323 @default.
• W2115813710 creator A5021514634 @default.
• W2115813710 creator A5027858713 @default.
• W2115813710 creator A5031553531 @default.
• W2115813710 creator A5032987754 @default.
• W2115813710 creator A5035798552 @default.
• W2115813710 creator A5050190308 @default.
• W2115813710 creator A5053489698 @default.
• W2115813710 creator A5069182089 @default.
• W2115813710 creator A5069748055 @default.
• W2115813710 creator A5073488441 @default.
• W2115813710 creator A5075171048 @default.
• W2115813710 date "2015-08-20" @default.
• W2115813710 modified "2023-10-07" @default.
• W2115813710 title "Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline" @default.
• W2115813710 cites W111163211 @default.
• W2115813710 cites W1523640001 @default.
• W2115813710 cites W1559559674 @default.
• W2115813710 cites W1575713723 @default.
• W2115813710 cites W1577377935 @default.
• W2115813710 cites W1626477266 @default.
• W2115813710 cites W1950887784 @default.
• W2115813710 cites W1977152516 @default.
• W2115813710 cites W1984477277 @default.
• W2115813710 cites W1993173846 @default.
• W2115813710 cites W2011666308 @default.
• W2115813710 cites W2013822060 @default.
• W2115813710 cites W2023915585 @default.
• W2115813710 cites W2031770999 @default.
• W2115813710 cites W2032518018 @default.
• W2115813710 cites W2061526396 @default.
• W2115813710 cites W2084302685 @default.
• W2115813710 cites W2089908289 @default.
• W2115813710 cites W2095545927 @default.
• W2115813710 cites W2098479045 @default.
• W2115813710 cites W2101979288 @default.
• W2115813710 cites W2103988568 @default.
• W2115813710 cites W2109561657 @default.
• W2115813710 cites W2113499049 @default.
• W2115813710 cites W2115581335 @default.
• W2115813710 cites W2117305280 @default.
• W2115813710 cites W2119065193 @default.
• W2115813710 cites W2119923334 @default.
• W2115813710 cites W2126324838 @default.
• W2115813710 cites W2130900820 @default.
• W2115813710 cites W2133399266 @default.
• W2115813710 cites W2135890715 @default.
• W2115813710 cites W2137853125 @default.
• W2115813710 cites W2144396863 @default.
• W2115813710 cites W2146827199 @default.
• W2115813710 cites W2151726995 @default.
• W2115813710 cites W2154079699 @default.
• W2115813710 cites W2157434805 @default.
• W2115813710 cites W2163193122 @default.
• W2115813710 cites W2163750567 @default.
• W2115813710 cites W2167645795 @default.
• W2115813710 cites W2170292198 @default.
• W2115813710 cites W2171316676 @default.
• W2115813710 cites W2201429547 @default.
• W2115813710 cites W4205350350 @default.
• W2115813710 cites W4234660912 @default.
• W2115813710 doi "https://doi.org/10.1200/jco.2015.61.1459" @default.
• W2115813710 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5478102" @default.
• W2115813710 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26195705" @default.
• W2115813710 hasPublicationYear "2015" @default.
• W2115813710 type Work @default.
• W2115813710 sameAs 2115813710 @default.
• W2115813710 citedByCount "261" @default.
• W2115813710 countsByYear W21158137102015 @default.
• W2115813710 countsByYear W21158137102016 @default.
• W2115813710 countsByYear W21158137102017 @default.
• W2115813710 countsByYear W21158137102018 @default.
• W2115813710 countsByYear W21158137102019 @default.
• W2115813710 countsByYear W21158137102020 @default.
• W2115813710 countsByYear W21158137102021 @default.
• W2115813710 countsByYear W21158137102022 @default.
• W2115813710 countsByYear W21158137102023 @default.
• W2115813710 crossrefType "journal-article" @default.
• W2115813710 hasAuthorship W2115813710A5001315712 @default.
• W2115813710 hasAuthorship W2115813710A5002951950 @default.
• W2115813710 hasAuthorship W2115813710A5005611441 @default.
• W2115813710 hasAuthorship W2115813710A5008665323 @default.
• W2115813710 hasAuthorship W2115813710A5021514634 @default.
• W2115813710 hasAuthorship W2115813710A5027858713 @default.
• W2115813710 hasAuthorship W2115813710A5031553531 @default.
• W2115813710 hasAuthorship W2115813710A5032987754 @default.
• W2115813710 hasAuthorship W2115813710A5035798552 @default.
• W2115813710 hasAuthorship W2115813710A5050190308 @default.
• W2115813710 hasAuthorship W2115813710A5053489698 @default.
• W2115813710 hasAuthorship W2115813710A5069182089 @default.
• W2115813710 hasAuthorship W2115813710A5069748055 @default.
• W2115813710 hasAuthorship W2115813710A5073488441 @default.
• W2115813710 hasAuthorship W2115813710A5075171048 @default.

• next